48 results
424B5
BEAM
Beam Therapeutics Inc
10 May 23
Prospectus supplement for primary offering
5:10pm
, business, and operational uncertainty, including as a result of geopolitical events or other global or regional events such as the COVID-19 pandemic.
All
8-K
EX-99.1
6qs8jj2vehgade2y2z1
7 Nov 22
Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results
7:00am
8-K
EX-99.1
d90d h7ibs4f29
9 Aug 22
Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results
7:00am
8-K
EX-99.1
qkpmrqll1u
1 Aug 22
Beam Therapeutics Announces FDA Clinical Hold on BEAM-201 IND Application
6:50am
8-K
9shhswha zws
1 Aug 22
Beam Therapeutics Announces FDA Clinical Hold on BEAM-201 IND Application
6:50am
8-K
EX-99.1
ke1od1qn5g3rvv4wtcx
9 May 22
Beam Therapeutics Announces Pipeline and Business Highlights and Reports First Quarter 2022 Financial Results
7:01am
8-K
EX-99.1
udeskkirtziqyw5vx1
28 Feb 22
Beam Therapeutics Reports Pipeline and Business Highlights, Planned 2022 Milestones and Fourth Quarter and Full Year 2021 Financial Results
7:00am
8-K
EX-99.1
ilxhs78bfbvo
10 Jan 22
Results of Operations and Financial Condition
6:45am
8-K
EX-99.2
p8pq05n4
10 Jan 22
Results of Operations and Financial Condition
6:45am
8-K
v6gg e7g7b
10 Jan 22
Results of Operations and Financial Condition
6:45am